From a biological point of view, it is intriguing why the p53 tumor suppressor activates TNFRSF14 because it acts as a ligand for the BTLA receptor expressed in T and B lymphocytes, inhibiting their activation. The gene discussed is TNFRSF14; the disease is neoplasm.